Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inozyme Pharma (INZY)
NASDAQ:INZY
Holding INZY?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -24.57M | $ -25.64M | $ -22.02M | $ -15.00M | $ -16.64M |
| EBITDA | $ -24.06M | $ -23.03M | $ -21.84M | $ -14.79M | $ -16.24M |
| Net Income Common Stockholders | $ -24.57M | $ -27.03M | $ -23.35M | $ -21.54M | $ -16.64M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 131.61M | $ 144.52M | $ 166.15M | $ 188.59M | $ 192.44M |
| Total Assets | $ 143.36M | $ 155.71M | $ 176.94M | $ 200.85M | $ 205.70M |
| Total Debt | $ 46.79M | $ 46.71M | $ 46.63M | $ 46.59M | $ 34.10M |
| Net Debt | $ -84.82M | $ -97.81M | $ -119.52M | $ -142.00M | $ -158.34M |
| Total Liabilities | $ 60.57M | $ 61.29M | $ 58.11M | $ 60.37M | $ 45.49M |
| Stockholders Equity | $ 82.79M | $ 94.43M | $ 118.81M | $ 140.48M | $ 160.21M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -24.54M | $ -23.66M | $ -24.57M | $ -18.59M | $ -18.88M |
| Operating Cash Flow | $ -24.53M | $ -23.66M | $ -24.53M | $ -18.49M | $ -18.87M |
| Investing Cash Flow | $ 23.35M | $ 17.82M | $ 10.39M | $ -6.47M | $ -44.62M |
| Financing Cash Flow | $ 10.52M | $ 458.00K | $ 159.00K | $ 12.52M | $ 69.72M |